Wall Street Experts
ver. ZuMIgo(08/25)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 685
EBIT TTM (mln): 100
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
Rok finansowy |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
20 |
20 |
25 |
32 |
62 |
92 |
134 |
233 |
416 |
471 |
579 |
622 |
498 |
740 |
1,029 |
834 |
1,140 |
1,031 |
845 |
702 |
Przychód Δ r/r |
0.0% |
-1.8% |
26.1% |
28.3% |
93.5% |
49.2% |
44.9% |
73.7% |
78.9% |
13.2% |
23.1% |
7.3% |
-20.0% |
48.8% |
39.0% |
-19.0% |
36.8% |
-9.6% |
-18.0% |
-17.0% |
Marża brutto |
39.9% |
52.4% |
56.4% |
61.8% |
73.9% |
79.8% |
82.8% |
89.9% |
92.2% |
92.2% |
91.4% |
92.5% |
89.0% |
89.7% |
92.9% |
92.5% |
92.9% |
91.8% |
87.1% |
84.6% |
EBIT (mln) |
-32 |
-21 |
-27 |
-22 |
-5 |
7 |
42 |
64 |
108 |
130 |
153 |
155 |
76 |
150 |
247 |
173 |
217 |
133 |
77 |
-8 |
EBIT Δ r/r |
0.0% |
-32.9% |
25.5% |
-19.1% |
-76.7% |
-237.3% |
512.9% |
50.3% |
69.7% |
19.9% |
17.8% |
1.3% |
-51.0% |
97.7% |
64.7% |
-30.1% |
25.6% |
-38.7% |
-42.3% |
-110.1% |
EBIT (%) |
-157.9% |
-107.8% |
-107.3% |
-67.7% |
-8.2% |
7.5% |
31.7% |
27.5% |
26.1% |
27.6% |
26.4% |
24.9% |
15.3% |
20.3% |
24.0% |
20.8% |
19.1% |
12.9% |
9.1% |
-1.1% |
Koszty finansowe (mln) |
0 |
0 |
1 |
1 |
3 |
3 |
5 |
6 |
5 |
2 |
7 |
4 |
6 |
6 |
6 |
6 |
1 |
2 |
0 |
1 |
EBITDA (mln) |
-32 |
-15 |
-21 |
-15 |
0 |
15 |
47 |
73 |
119 |
154 |
181 |
185 |
118 |
202 |
319 |
225 |
253 |
195 |
139 |
80 |
EBITDA(%) |
-157.9% |
-76.8% |
-85.1% |
-48.4% |
0.4% |
15.9% |
35.1% |
31.3% |
28.7% |
32.8% |
31.2% |
29.7% |
23.8% |
27.3% |
31.0% |
27.0% |
22.2% |
18.9% |
16.5% |
11.4% |
Podatek (mln) |
-4 |
0 |
2 |
1 |
1 |
3 |
5 |
5 |
15 |
18 |
19 |
21 |
10 |
13 |
26 |
12 |
4 |
-5 |
-11 |
-34 |
Zysk Netto (mln) |
-30 |
-22 |
-30 |
-23 |
-7 |
4 |
31 |
53 |
87 |
118 |
128 |
139 |
75 |
151 |
227 |
165 |
213 |
138 |
109 |
40 |
Zysk netto Δ r/r |
0.0% |
-27.4% |
34.1% |
-20.8% |
-68.7% |
-150.3% |
737.4% |
72.4% |
64.1% |
35.6% |
8.0% |
8.6% |
-45.7% |
100.5% |
50.6% |
-27.6% |
29.5% |
-35.3% |
-21.3% |
-63.4% |
Zysk netto (%) |
-150.9% |
-111.5% |
-118.5% |
-73.2% |
-11.8% |
4.0% |
23.0% |
22.9% |
21.0% |
25.1% |
22.0% |
22.3% |
15.1% |
20.4% |
22.1% |
19.7% |
18.7% |
13.4% |
12.9% |
5.7% |
EPS |
-0.0428 |
-0.031 |
-0.0416 |
-0.033 |
-0.0103 |
0.0052 |
0.0434 |
0.0749 |
0.1 |
0.13 |
0.14 |
0.15 |
0.0816 |
0.16 |
0.25 |
0.17 |
0.2 |
0.13 |
0.11 |
0.0383 |
EPS (rozwodnione) |
-0.0428 |
-0.031 |
-0.0416 |
-0.033 |
-0.0103 |
0.0052 |
0.0434 |
0.0749 |
0.1 |
0.13 |
0.14 |
0.15 |
0.0816 |
0.16 |
0.25 |
0.17 |
0.2 |
0.13 |
0.11 |
0.0383 |
Ilośc akcji (mln) |
710 |
710 |
710 |
710 |
710 |
710 |
710 |
710 |
864 |
923 |
923 |
923 |
923 |
923 |
923 |
989 |
1,041 |
1,030 |
1,034 |
1,037 |
Ważona ilośc akcji (mln) |
710 |
710 |
710 |
710 |
710 |
710 |
710 |
710 |
864 |
923 |
923 |
923 |
923 |
923 |
923 |
989 |
1,045 |
1,031 |
1,034 |
1,037 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |